Optra Health Revenue and Competitors

OptraHEALTH® is focused on improving outcomes for patients, genetic testing labs, healthcare and life science organizations by utilizing our next-generation Artificial Intelligence (AI) Platform. Our flagship product GeneFAX™ is the AI guided genetic test recommendation and e-counselling platform with intelligent ChatBOT interfaces. GeneFAX™ is the Digital Genetic Navigator trained on Genetic Health Knowledge-base to empower organizations for performing guidelines based patient triage, pre-test education, post-test counseling, helping physicians recommend appropriate genetic tests. GeneFAX™ also enables patients to connect with a genetic counselor at any time. GeneFAX™ provides business insights for organizations enhancing operational efficiency with increased revenues and better patient engagements. It automates the independent case review and pre-authorization process for Payors and providers for reimbursements. Pharmaceutical companies benefit from Real World data Analytics by de-risking elements of early discovery by focusing on identification of high-responding patient cohorts through GeneFAX™. Using robust genomic data and longitudinal clinical data, GeneFAX™ based RWE helps identifying biomarkers of Therapeutic and Companion Diagnostics interest and to optimize a drug/ test development strategy. Using this platform OptraHEALTH® recently launched HealthFAX.AI™ for COVID-19 which is being used by physician networks and testing companies as ChatBOT for patient triaging and tracing.